PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
Gauges a company's environmental, social, and governance practices.
59.17
ESG score 90-95% of EYEN's 63.16. Bill Ackman would demand clear ESG improvement catalysts.
58.08
Environmental score exceeding 1.2x EYEN's 48.10. Mohnish Pabrai would examine if this environmental advantage creates sustainable cost advantages.
59.30
Social score 80-90% of EYEN's 69.68. Walter Schloss would scrutinize stakeholder relations and reputational exposure.
60.13
Governance score 80-90% of EYEN's 71.70. Walter Schloss would scrutinize management accountability and board independence.